These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30661282)

  • 21. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
    Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
    BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.
    Tamura I; Kurimura O; Koda T; Ichimura H; Katayama S; Kurimura T; Inaba Y
    J Gastroenterol Hepatol; 1993; 8(5):433-6. PubMed ID: 8218990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
    Jang TY; Wei YJ; Liu TW; Yeh ML; Liu SF; Hsu CT; Hsu PY; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
    Sci Rep; 2021 Apr; 11(1):8184. PubMed ID: 33854160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis delta infection among persons living with HIV in Europe.
    Béguelin C; Atkinson A; Boyd A; Falconer K; Kirkby N; Suter-Riniker F; Günthard HF; Rockstroh JK; Mocroft A; Rauch A; Peters L; Wandeler G;
    Liver Int; 2023 Apr; 43(4):819-828. PubMed ID: 36625770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
    Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
    Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
    Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
    J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
    Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen PJ; Cheon ME; Chuang WL; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg AS; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu YC; Hu CC; Huang JF; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao JH; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee MH; Lim YS; Marotta PJ; Navas MC; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang HI; Yu ML; Zuckerman E;
    J Hepatol; 2023 Aug; 79(2):576-580. PubMed ID: 37030400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New epidemiology of hepatitis delta.
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2020 Feb; 40 Suppl 1():48-53. PubMed ID: 32077599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The medical impact of hepatitis D virus infection in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
    Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum β2-microglobulin in individuals coinfected with hepatitis B and hepatitis D virus in a rural settings in Southwest Nigeria.
    Okoror LE; Ajayi AO; Ijalana OB
    BMC Res Notes; 2017 Dec; 10(1):719. PubMed ID: 29221492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat.
    Patel FM; Goswami PN
    Indian J Med Res; 2016 Jun; 143(6):798-800. PubMed ID: 27748305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
    Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
    Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Hepatitis Delta Virus Among Pregnant Women of Pakistan.
    Aftab M; Naz S; Aftab B; Ali A; Rafique S; Fatima Z; Inamullah ; Idrees M
    Viral Immunol; 2019 Oct; 32(8):335-340. PubMed ID: 31553269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
    J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis delta virus and hepatocellular carcinoma: an update.
    Romeo R; Petruzziello A; Pecheur EI; Facchetti F; Perbellini R; Galmozzi E; Khan NU; Di Capua L; Sabatino R; Botti G; Loquercio G
    Epidemiol Infect; 2018 Oct; 146(13):1612-1618. PubMed ID: 29991359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.